FDA Inspection 1293784 — Adam J. Bruggeman, MD

Adam J. Bruggeman, MD — FEI 3040625235

The FDA completed an inspection of Adam J. Bruggeman, MD on Nov 19, 2025 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 19, 2025
Fiscal Year
2026
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
San Antonio, TX (United States)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.